2nd NO-AD International Seminar on Alzheimer’s Disease and Ageing
MRI scan of the human brain. Illustration image: Colourbox.com.
Alzheimer’s disease (AD) is a common form of dementia affecting 35 to 50 million individuals worldwide. Since its discovery for more than 110 years ago, there is still no cure for AD despite decades of enormous efforts.
Big challenges are
- More molecular mechanisms on how AD is developed need to be unveiled;
- easy accessible and affordable approaches to identify individuals with early AD are not available, which makes it impossible for early intervention or treatment;
- it is urgent to develop strategies or treatments to delay, slow down or prevent AD;
- it is necessary to propel the development of effective anti-AD drugs or therapies using modern techniques (e.g., CRISPR-Cas9 and artificial intelligence, AI).
After the 1st NO-AD meeting (website here and recorded videos here) on the 25th November 2020, the 2nd NO-AD meeting will be held on the 20th October 2021. The seminar is jointly organised by the University of Oslo, (UiO, Norway) and the Akershus University Hospital (Ahus, Norway), the University of Oxford (Oxford, UK), and the Charles University (CU, Czech Republic).
This one-day hybrid meeting (physical attendance + zoom) will provide updates on all these important topics with talks by leading experts from various fields.
- Prof. Nancy Ip (HKUST, Hong Kong)
- Prof. Li-Huei Tsai (MIT, USA)
- Associate Professor Alejo J Nevado-Holgado (Oxford, UK)
- Associate Professor Evandro F. Fang (UiO/Ahus, Norway)
- Professor Noel Buckley (Oxford, UK)
- Professor Linda Hildegard Bergersen (UiO/Ahus, Norway)
- Dr. Katerina Cechova (Charles University, Czech Republic)
- Associate Professor Martin Vyhnálek (Charles University, Czech Republic)
- Professor Tormod Fladby (UiO/Ahus, Norway)
- Professor Jan Laczó (Charles University, Czech Republic)
- Dr. Liu Shi (Oxford, UK)
- Dr. Domenica Caponio (UiO/Ahus, Norway)
If you want to attend physically, please open this link and register at the bottom of the page that you are directed to. Note, due to COVID-19 measures, we can only fit 36 seats in the meeting room. First register first serve. We will send you an email 1 to 2 weeks before the meeting to inform you whether there is a seat for you or not.